Characterization of the Genetic Landscape of High-Grade B-cell Lymphoma to Elucidate Molecular Determinants and Identify Therapeutic Targets

表征高级别 B 细胞淋巴瘤的遗传景观，以阐明分子决定因素并确定治疗靶点

• 批准号: 459075
• 负责人: Collinge Brett J
• 金额: $ 7.65万
• 依托单位: BC Cancer, part of PHSA (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-11-01 至 2024-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=459075&lang=en
• 关键词: Genomics; Lymphoma; Molecular Classification; Mutational Landscape

Lymphoma is the 6th most common form of cancer in Canada, with one in 38 Canadians expected to develop lymphoma during their lifetime. While advances in treatment options over the past two decades have drastically improved survival rates in some forms of

淋巴瘤是加拿大第六常见的癌症，每38名加拿大人中就有一人预计在一生中会患上淋巴瘤。虽然过去二十年来治疗方案的进步大大提高了某些形式的生存率，